13F-HR filed by Vivo Capital, LLC
Vivo Capital, LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 60 holding rows worth $2,227,159,000.
- Accession
- 0001213900-21-059130
- Filer
- CIK 1674712
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 60 entries on the cover page, a total value of $2,227,159,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,227,158,000 with VALUE read as thousands by filing date, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 4,220,048 | $311,693,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 12,486,787 | $223,201,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 4,884,341 | $187,217,000 | thousands by filing date | |
| NEW FRONTIER HEALTH CORP | G6461G106 | ORD SHS | 14,300,000 | $160,589,000 | thousands by filing date | |
| AMYRIS INC | 03236M200 | COM NEW | 11,642,195 | $159,847,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 760,606 | $121,233,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 5,966,527 | $96,896,000 | thousands by filing date | |
| GENETRON HLDGS LTD | 37186H100 | ADS | 6,339,860 | $87,807,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 2,987,331 | $64,377,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 3,547,030 | $55,014,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 3,871,291 | $48,972,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 1,917,074 | $42,022,000 | thousands by filing date | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,427,213 | $41,917,000 | thousands by filing date | |
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 5,900,000 | $38,173,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 4,283,014 | $37,305,000 | thousands by filing date | |
| IMPEL PHARMACEUTICALS INC | 45258K109 | CMN | 2,884,789 | $35,137,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,238,575 | $34,135,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 2,937,093 | $28,784,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,641,913 | $28,651,000 | thousands by filing date | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 2,675,133 | $27,875,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 484,453 | $26,156,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 488,751 | $24,711,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,300,000 | $21,385,000 | thousands by filing date | |
| SERA PROGNOSTICS INC | 81749D107 | CMN | 1,856,011 | $20,620,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 174,999 | $18,443,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 940,754 | $16,934,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 6,907,189 | $16,715,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,749,918 | $15,070,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 512,225 | $14,245,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 410,000 | $13,428,000 | thousands by filing date | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 961,359 | $13,334,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 1,553,500 | $12,164,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,420,941 | $11,950,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 872,151 | $11,129,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 500,732 | $11,081,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 517,280 | $10,889,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 433,585 | $10,358,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 525,262 | $9,838,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 442,000 | $9,724,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 577,642 | $9,381,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 388,144 | $9,028,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 137,411 | $8,579,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 1,056,067 | $8,449,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 286,064 | $8,307,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 530,991 | $7,800,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 853,143 | $6,714,000 | thousands by filing date | |
| Valneva SE ADR | 92025Y103 | COM | 200,000 | $6,280,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 320,000 | $6,115,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 1,232,394 | $5,743,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 539,263 | $5,371,000 | thousands by filing date | |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 2,840,909 | $5,057,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 399,830 | $4,610,000 | thousands by filing date | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 496,843 | $3,870,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 469,588 | $3,137,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 1,325,736 | $3,049,000 | thousands by filing date | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 14,798 | $2,154,000 | thousands by filing date | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 140,255 | $1,619,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 105,000 | $1,595,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 167,863 | $779,000 | thousands by filing date | |
| METACRINE INC | 59101E103 | COM | 146,426 | $502,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-21-059130 | this filing | 2021-11-15 | acceptance time not in the bulk data set |